[Current therapeutics in infectious dermatology].
NEW AGENTS: Among new treatments used for infectious dermatology diseases, new agents for genital herpes, valaciclovir and famciclovir, have greatly simplified therapeutic schemes. Cidofovir has also been shown to be effective against aciclovir-resistant cutaneous and mucosal herpetic lesions and for the treatment of molluscum contagiosum. NEW ADMINISTRATION ROUTES: For genital papillomavirus infections, trials using systemic or intralesional administered interferon have not provided conclusive evidence but imiquimode appears to be quite promising. Itaconazole and fluconazole are effective for onchomycoses. NEW POSSIBILITIES: Ivermectine is effective against scabies, but must be reserved for particularly severe forms. Finally, the emergence of Neisseria gonorrhoeae strains resistant to fluoroquinolones is disquieting.
Lascaux
A S
AS
Service d'Immunologie clinique, Hôpital Henri Mondor, Créteil. clinic.immunol@hmn.aphop-paris.fr
Chosidow
O
O
D000935:Antifungal Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D003881:Dermatomycoses / Q000188:drug therapy; D006561:Herpes Simplex / Q000188:drug therapy; D006801:Humans; D008976:Molluscum Contagiosum / Q000188:drug therapy; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000188:drug therapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D017193:Skin Diseases, Viral / Q000188:drug therapy; D014412:Tumor Virus Infections / Q000188:drug therapy
D000935:Antifungal Agents; D000998:Antiviral Agents
Actualités thérapeutiques en dermatologie infectieuse.